C Maxit1, I Denzler2, D Marchione1, G Agosta1, J Koster3, R J A Wanders3, S Ferdinandusse3, H R Waterham3. 1. Department of Child Neurology, Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina. 2. Department of Child Neurology, Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina. ines.denzler@hospitalitaliano.org.ar. 3. Laboratory Genetic Metabolic Diseases, Academic Medical Centre, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Peroxisome biogenesis disorders (PBDs) may have a variable clinical expression, ranging from severe, lethal to mild phenotypes with progressive evolution. PBDs are autosomal recessive disorders caused by mutations in PEX genes, which encode proteins called peroxins, involved in the assembly of the peroxisome. Patient Description: We herein report a patient who is currently 9 years old and who is compound heterozygous for two novel mutations in the PEX3 gene. RESULTS: Mild biochemical abnormalities of the peroxisomal parameters suggested a Zellweger spectrum defect in the patient. Sequence analysis of the PEX3 gene identified two novel heterozygous, pathogenic mutations. CONCLUSION: Mutations in PEX3 usually result in a severe, early lethal phenotype. We report a patient compound heterozygous for two novel mutations in the PEX3 gene, who is less affected than previously reported patients with a defect in the PEX3 gene. Our findings indicate that PEX3 defects may cause a disease spectrum similar as previously observed for other PEX gene defects.
BACKGROUND:Peroxisome biogenesis disorders (PBDs) may have a variable clinical expression, ranging from severe, lethal to mild phenotypes with progressive evolution. PBDs are autosomal recessive disorders caused by mutations in PEX genes, which encode proteins called peroxins, involved in the assembly of the peroxisome. Patient Description: We herein report a patient who is currently 9 years old and who is compound heterozygous for two novel mutations in the PEX3 gene. RESULTS: Mild biochemical abnormalities of the peroxisomal parameters suggested a Zellweger spectrum defect in the patient. Sequence analysis of the PEX3 gene identified two novel heterozygous, pathogenic mutations. CONCLUSION: Mutations in PEX3 usually result in a severe, early lethal phenotype. We report a patient compound heterozygous for two novel mutations in the PEX3 gene, who is less affected than previously reported patients with a defect in the PEX3 gene. Our findings indicate that PEX3 defects may cause a disease spectrum similar as previously observed for other PEX gene defects.
Authors: Merel S Ebberink; Petra A W Mooijer; Jeannette Gootjes; Janet Koster; Ronald J A Wanders; Hans R Waterham Journal: Hum Mutat Date: 2011-01 Impact factor: 4.878
Authors: Avraham Zeharia; Merel S Ebberink; Ronald J A Wanders; Hans R Waterham; Alisa Gutman; Andreea Nissenkorn; Stanley H Korman Journal: J Hum Genet Date: 2007-05-30 Impact factor: 3.172
Authors: A C Muntau; A Holzinger; P U Mayerhofer; J Gärtner; A A Roscher; S Kammerer Journal: Biochem Biophys Res Commun Date: 2000-02-24 Impact factor: 3.575
Authors: Luc Régal; Merel S Ebberink; Nathalie Goemans; Ronald J A Wanders; Linda De Meirleir; Jacques Jaeken; Maarten Schrooten; Rudy Van Coster; Hans R Waterham Journal: Ann Neurol Date: 2010-08 Impact factor: 10.422
Authors: Ingeborg Hauth; Hans R Waterham; Ronald J A Wanders; Saskia N van der Crabben; Clara D M van Karnebeek Journal: Cold Spring Harb Mol Case Stud Date: 2022-03-24